 Virginia Sarapura
Concepts (129)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glycoprotein Hormones, alpha Subunit | 10 | 2006 | 23 | 0.810 |
Why?
| | Pituitary Neoplasms | 9 | 2006 | 190 | 0.430 |
Why?
| | Thyrotropin | 10 | 1998 | 120 | 0.330 |
Why?
| | Promoter Regions, Genetic | 8 | 1998 | 1246 | 0.330 |
Why?
| | Triiodothyronine | 4 | 2005 | 54 | 0.270 |
Why?
| | Transcription Factors | 6 | 2006 | 1734 | 0.250 |
Why?
| | Thyrotropin, beta Subunit | 1 | 2006 | 5 | 0.240 |
Why?
| | Receptors, Thyroid Hormone | 2 | 1997 | 18 | 0.230 |
Why?
| | Pituitary Gland | 3 | 1998 | 149 | 0.220 |
Why?
| | Thyroxine | 3 | 2001 | 66 | 0.170 |
Why?
| | Thyroid Neoplasms | 4 | 2010 | 350 | 0.160 |
Why?
| | Thyroiditis, Autoimmune | 2 | 2017 | 16 | 0.150 |
Why?
| | Transfection | 10 | 2005 | 926 | 0.150 |
Why?
| | Gene Expression | 4 | 1998 | 1476 | 0.140 |
Why?
| | Homeodomain Proteins | 4 | 2005 | 523 | 0.140 |
Why?
| | Graves Disease | 1 | 2017 | 32 | 0.130 |
Why?
| | Thyroid Gland | 1 | 2017 | 89 | 0.130 |
Why?
| | Tumor Cells, Cultured | 8 | 1998 | 886 | 0.120 |
Why?
| | Gene Expression Regulation | 5 | 1998 | 2597 | 0.110 |
Why?
| | Hyperprolactinemia | 1 | 1993 | 6 | 0.100 |
Why?
| | Transcription, Genetic | 6 | 2002 | 1454 | 0.100 |
Why?
| | RNA, Messenger | 5 | 2005 | 2803 | 0.100 |
Why?
| | Blotting, Northern | 6 | 2002 | 203 | 0.090 |
Why?
| | B-Lymphocytes | 1 | 2017 | 870 | 0.090 |
Why?
| | DNA, Complementary | 2 | 2006 | 273 | 0.090 |
Why?
| | Luciferases | 3 | 1998 | 153 | 0.090 |
Why?
| | Mice | 17 | 2006 | 18329 | 0.080 |
Why?
| | Base Sequence | 5 | 1998 | 2170 | 0.080 |
Why?
| | Thyroid Diseases | 1 | 2010 | 44 | 0.080 |
Why?
| | Receptors, Somatostatin | 2 | 2001 | 24 | 0.080 |
Why?
| | Nuclear Proteins | 3 | 2005 | 740 | 0.070 |
Why?
| | Molecular Sequence Data | 5 | 1998 | 2883 | 0.070 |
Why?
| | Chromosome Mapping | 1 | 1990 | 506 | 0.070 |
Why?
| | T-Lymphocytes | 1 | 2017 | 1996 | 0.070 |
Why?
| | MSX1 Transcription Factor | 2 | 1998 | 5 | 0.070 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2005 | 1443 | 0.070 |
Why?
| | RNA, Neoplasm | 2 | 2005 | 83 | 0.070 |
Why?
| | Enhancer Elements, Genetic | 3 | 1998 | 191 | 0.060 |
Why?
| | Animals | 18 | 2010 | 38030 | 0.060 |
Why?
| | Pituitary Gland, Anterior | 3 | 1998 | 37 | 0.060 |
Why?
| | Receptors, Thyrotropin | 1 | 2006 | 2 | 0.060 |
Why?
| | Precision Medicine | 1 | 2010 | 459 | 0.060 |
Why?
| | DNA | 6 | 1998 | 1435 | 0.050 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2005 | 749 | 0.050 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 977 | 0.050 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2005 | 376 | 0.050 |
Why?
| | Thyroid Hormones | 2 | 2002 | 68 | 0.050 |
Why?
| | Mice, Knockout | 2 | 2006 | 3124 | 0.040 |
Why?
| | Cell Line | 3 | 1997 | 2823 | 0.040 |
Why?
| | Mutagenesis, Site-Directed | 2 | 1998 | 376 | 0.040 |
Why?
| | Mice, Inbred C57BL | 4 | 2006 | 5983 | 0.040 |
Why?
| | Binding Sites | 3 | 1998 | 1310 | 0.040 |
Why?
| | Gonadotropins, Pituitary | 1 | 1998 | 22 | 0.040 |
Why?
| | Paired Box Transcription Factors | 1 | 1998 | 43 | 0.040 |
Why?
| | Hypothyroidism | 4 | 2002 | 67 | 0.040 |
Why?
| | B7-2 Antigen | 1 | 2017 | 27 | 0.030 |
Why?
| | Consensus Sequence | 1 | 1997 | 73 | 0.030 |
Why?
| | Deoxyribonuclease I | 1 | 1997 | 41 | 0.030 |
Why?
| | Mutagenesis | 1 | 1998 | 194 | 0.030 |
Why?
| | Clonal Anergy | 1 | 2017 | 52 | 0.030 |
Why?
| | DNA Mutational Analysis | 1 | 1998 | 407 | 0.030 |
Why?
| | Blotting, Southern | 1 | 1997 | 85 | 0.030 |
Why?
| | Cell Nucleus | 2 | 1998 | 588 | 0.030 |
Why?
| | Gene Library | 1 | 1997 | 122 | 0.030 |
Why?
| | Repetitive Sequences, Nucleic Acid | 1 | 1997 | 117 | 0.030 |
Why?
| | Polymerase Chain Reaction | 2 | 1997 | 1041 | 0.030 |
Why?
| | Gene Deletion | 1 | 1998 | 391 | 0.030 |
Why?
| | Cloning, Molecular | 1 | 1997 | 538 | 0.030 |
Why?
| | Plasmids | 1 | 1997 | 373 | 0.030 |
Why?
| | Epitopes | 1 | 2017 | 473 | 0.030 |
Why?
| | Cells, Cultured | 3 | 2017 | 4148 | 0.030 |
Why?
| | Immune Tolerance | 1 | 2017 | 385 | 0.030 |
Why?
| | Lymphocyte Activation | 1 | 2017 | 1132 | 0.020 |
Why?
| | Pergolide | 1 | 1993 | 1 | 0.020 |
Why?
| | Bromocriptine | 1 | 1993 | 31 | 0.020 |
Why?
| | Prolactin | 1 | 1993 | 87 | 0.020 |
Why?
| | Neoplasm Transplantation | 1 | 1993 | 246 | 0.020 |
Why?
| | Receptors, Dopamine D2 | 1 | 1993 | 93 | 0.020 |
Why?
| | Basophils | 1 | 1992 | 52 | 0.020 |
Why?
| | Restriction Mapping | 1 | 1990 | 81 | 0.020 |
Why?
| | Graves Ophthalmopathy | 1 | 2010 | 13 | 0.020 |
Why?
| | DNA-Binding Proteins | 2 | 1998 | 1480 | 0.020 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 1990 | 92 | 0.020 |
Why?
| | Autoantibodies | 1 | 2017 | 1509 | 0.020 |
Why?
| | Thyroid Nodule | 1 | 2010 | 57 | 0.020 |
Why?
| | Genes | 1 | 1990 | 227 | 0.020 |
Why?
| | Mice, Transgenic | 3 | 1998 | 2188 | 0.020 |
Why?
| | Autoimmune Diseases | 1 | 2010 | 468 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 2 | 2001 | 3904 | 0.010 |
Why?
| | Organ Specificity | 2 | 1998 | 309 | 0.010 |
Why?
| | Genes, cdc | 1 | 2005 | 11 | 0.010 |
Why?
| | Wnt Proteins | 1 | 2005 | 133 | 0.010 |
Why?
| | Humans | 7 | 2017 | 145474 | 0.010 |
Why?
| | Cattle | 2 | 1998 | 946 | 0.010 |
Why?
| | Down-Regulation | 1 | 2005 | 618 | 0.010 |
Why?
| | In Situ Hybridization | 1 | 2002 | 318 | 0.010 |
Why?
| | Hyperplasia | 1 | 2001 | 177 | 0.010 |
Why?
| | Female | 4 | 2017 | 78844 | 0.010 |
Why?
| | Cell Division | 1 | 2002 | 756 | 0.010 |
Why?
| | Male | 5 | 2017 | 72842 | 0.010 |
Why?
| | Signal Transduction | 1 | 1993 | 5216 | 0.010 |
Why?
| | Fushi Tarazu Transcription Factors | 1 | 1998 | 5 | 0.010 |
Why?
| | Steroidogenic Factor 1 | 1 | 1998 | 13 | 0.010 |
Why?
| | Sequence Homology | 1 | 1998 | 43 | 0.010 |
Why?
| | Gene Expression Profiling | 1 | 2005 | 1767 | 0.010 |
Why?
| | Treatment Outcome | 1 | 1993 | 11772 | 0.010 |
Why?
| | Cell Cycle Proteins | 1 | 2002 | 630 | 0.010 |
Why?
| | Sequence Deletion | 1 | 1998 | 190 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2001 | 1716 | 0.010 |
Why?
| | Transgenes | 1 | 1998 | 190 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2005 | 3542 | 0.010 |
Why?
| | Autoradiography | 1 | 1997 | 66 | 0.010 |
Why?
| | RNA-Directed DNA Polymerase | 1 | 1997 | 35 | 0.010 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 1998 | 207 | 0.010 |
Why?
| | Risk Factors | 1 | 2010 | 10885 | 0.010 |
Why?
| | RNA | 1 | 2001 | 910 | 0.010 |
Why?
| | Sequence Analysis, DNA | 1 | 1998 | 777 | 0.010 |
Why?
| | Hyperthyroidism | 1 | 1994 | 22 | 0.010 |
Why?
| | beta-Galactosidase | 1 | 1994 | 76 | 0.010 |
Why?
| | Tissue Distribution | 1 | 1994 | 335 | 0.010 |
Why?
| | Transcription Factor Pit-1 | 1 | 1993 | 26 | 0.010 |
Why?
| | Luteinizing Hormone | 1 | 1994 | 207 | 0.010 |
Why?
| | Apoptosis | 1 | 2002 | 2440 | 0.010 |
Why?
| | Follicle Stimulating Hormone | 1 | 1994 | 266 | 0.010 |
Why?
| | Recombinant Fusion Proteins | 1 | 1994 | 666 | 0.010 |
Why?
| | Blotting, Western | 1 | 1993 | 1179 | 0.010 |
Why?
| | Protein Biosynthesis | 1 | 1993 | 452 | 0.010 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 1990 | 157 | 0.000 |
Why?
| | Peptide Fragments | 1 | 1990 | 693 | 0.000 |
Why?
|
|
Sarapura's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|